Apogee Therapeutics (APGE) Depreciation & Amortization (CF) (2024 - 2026)
Apogee Therapeutics' (APGE) quarterly Depreciation & Amortization (CF) came in at $408000.0 in Q1 2026, up 104.0% year-on-year from $200000.0 in Q1 2025, and little changed on a QoQ basis from $406000.0 in Q4 2025.
Apogee Therapeutics (APGE) Depreciation & Amortization (CF) (2024 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has 3 years of Depreciation & Amortization (CF) data on file, last reported at $408000.0 in Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 104.0% year-over-year to $408000.0 in Q1 2026; TTM through Mar 2026 was $1.6 million, a 332.71% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 650.26% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $408000.0, roughly flat from $406000.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for APGE reached as high as $408000.0 in Q1 2026 and fell as low as $29000.0 in Q1 2024.
- Historically, Depreciation & Amortization (CF) has averaged $224000.0 across 3 years, with a median of $200000.0 in 2025.
- Across the five-year window, Depreciation & Amortization (CF) soared 1011.11% in 2025 and soared 104.0% in 2026, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $89000.0 in 2024, then jumped by 356.18% to $406000.0 in 2025, then grew by 0.49% to $408000.0 in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $408000.0 in Q1 2026, $406000.0 in Q4 2025, and $400000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Apogee Therapeutics | 9.35 Bn | 8.29 Bn | - | 408,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 408,000.00 |
| Mar 31, 2026 | 408,000.00 |
| Dec 31, 2025 | 406,000.00 |
| Dec 31, 2025 | 406,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 89,000.00 |
| Dec 31, 2024 | 89,000.00 |
| Sep 30, 2024 | 48,000.00 |
| Sep 30, 2024 | 48,000.00 |
| Jun 30, 2024 | 36,000.00 |
| Jun 30, 2024 | 36,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Mar 31, 2024 | 29,000.00 |